is glp 1/gip the same as tirzepatide Understanding Difference: While both peptides are powerful metabolic tools, their pharmacology distinct: • (Manjaro): This is a dual agonist targeting GLP-1 (Glucagon-like peptide-1) and GIP (Glucose-dependent insulinotropic Unveiling Tirzepatide's Therapeutic Spectrum: A

Here is how the numbers compare across different timeframes: A 2026 analysis presented at the American Society for Metabolic and Bariatric Surgery found that total costs for brand GLP-1 treatment were about $17,000 more than sleeve gastrectomy over two years ($58,600 vs $41,400)

However, not all of the data is supportive and metformin, as shown in C

Combining both treatments can improve outcomes, though managing side effects remains critical

[18,19] Some GLP-1, such as liraglutide and exenatide, have shown potential outcomes in non-pregnant populations for improving blood glucose levels and promoting weight loss, making them a potentially appealing option for GDM

Its a once-daily medication in the GLP-1 family